New Safety Framework Mixes Current Efforts, New Investments At US FDA
Executive Summary
In a new "action plan," FDA is stitching together a plethora of ongoing and proposed initiatives to help spur product safety and quality efforts through increased regulatory authority and more incentives for device-makers.
You may also be interested in...
Researchers Question Efficacy Of FDA’s Device Surveillance System
Recent medical journal papers call into question the effectiveness of the US agency’s medical device surveillance system, arguing that it’s too slow to pick up on safety signals.
Lack Of Funding Stalls Major US FDA Cybersecurity Initiative
A public-private partnership board long touted by top US FDA officials to help address cybersecurity threats has hit a funding wall. The agency received less than half of what it asked for in the FY 2019 budget for its digital efforts, including its cybersecurity strategy, leading it to make some tough choices.
‘Disease Doesn’t Respect Silos’: Sharpless Sets Flexibility As Priority
Acting US FDA Commissioner Ned Sharpless described his vision for an efficient, adaptable agency on 2 May at the Food & Drug Law Institute’s annual conference in Washington, DC.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests:
